ArticleJournal of surgical oncology2026
The Impact of Breast Reconstruction on Smoking Cessation Among Patients With Breast Cancer.
Article in Journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Breast cancer diagnosis as a window of opportunity for smoking cessation: analysis of changes in smoking behaviour in 736 smoking breast cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesIn this study, we aim to evaluate trends in smoking cessation among breast cancer patients, with a particular focus on the impact of breast reconstruction surgery, and to assess if breast reconstruction surgery represents a unique opportunity for intervention.
methodsWe performed a retrospective analysis of active smokers with a new diagnosis of breast cancer who were treated with any surgical or non-surgical intervention at our institution between 2015 and 2024. Quitting was defined as continuous cessation for at least 30 days. Patients who quit were followed for at least 6 months after cessation.
resultsOne hundred twenty-seven patients were identified. Mean age was 56 years (range 35-87). Eighty patients (63%) underwent surgery without reconstruction, 26 patients (20%) underwent surgery with reconstruction, and 21 patients (17%) received non-surgical treatment only. Overall, 26% (34/127) of patients quit smoking. Among patients undergoing surgical treatment, patients undergoing reconstruction were significantly more likely to quit smoking than those without reconstruction (50% [13/26] vs. 23% [18/80]; p = 0.007). Patients receiving reconstruction were also significantly more likely to quit preoperatively (77% [10/13] vs. 33% [12/18]; p = 0.048). Median time from initial visit with surgical oncology to surgery was longer among reconstructive patients who quit pre-operatively (90.5 days [IQR: 44-164]) than those who quit post-operatively or did not quit (45 days [IQR: 26-68]; p = 0.13).
conclusionsPatients receiving breast reconstruction are significantly more likely to quit smoking than those who do not. Longer median time to surgery among patients who quit pre-operatively emphasizes the need for targeted cessation interventions that allow for timely oncologic care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.